Medical device manufacturers in the mid-market face a persistent compliance headache: ISO 13485 requires regular calibration of the equipment used in production and quality control, but the capital cost of high-precision calibration instruments and the expertise to operate them can be prohibitive. A new model is emerging in response: shared calibration laboratories, where several non-competing firms pool their testing capacity and costs.
This explainer examines what shared calibration labs are, why they are gaining traction, who benefits, and what the future may hold. It is based on publicly available information and industry patterns, not on proprietary data.
What Is a Shared Calibration Lab?
A shared calibration lab is a facility operated by a consortium of medical device manufacturers, or by a third-party provider on behalf of several clients, to perform calibration services that each firm would otherwise need to source individually. The lab typically houses high-end calibration equipment—such as digital multimeters, pressure calibrators, temperature baths, and dimensional measurement tools—and employs trained metrologists.
Participating firms pay a membership or usage fee, gaining access to calibrated instruments and documented procedures that satisfy ISO 13485 clause 7.6 (control of monitoring and measuring equipment). The lab operates under a quality management system that is itself audited, often to ISO/IEC 17025, which is the international standard for testing and calibration laboratories.
The model is not entirely new—third-party calibration services have existed for decades—but the shared-lab approach is distinct in that it is often co-owned or long-term contracted by a group of manufacturers, giving them more control over scheduling, turnaround times, and the specific equipment available.
Why Is This Emerging Now?
Several factors are converging to make shared calibration labs more attractive for mid-market firms.
First, ISO 13485:2016 places greater emphasis on risk management and documented traceability. Calibration records must be complete, accurate, and readily available for audits. This raises the administrative burden and the cost of non-conformance. A shared lab with a robust quality system can provide that documentation more efficiently than a small in-house team.
Second, the cost of high-end calibration equipment has not fallen in line with the budgets of many mid-market firms. A single reference standard can cost tens of thousands of pounds, and annual recalibration of that standard adds recurring expense. For a firm producing a limited range of devices, the utilisation rate of such equipment may be low, making the investment hard to justify.
Third, the medical device supply chain is becoming more specialised. Many mid-market firms are contract manufacturers or component suppliers to larger OEMs. These firms must demonstrate ISO 13485 compliance to win and retain contracts, but they often lack the scale to build a full metrology department. A shared lab offers a credible, auditable solution.
Fourth, the post-pandemic focus on supply chain resilience has encouraged collaboration. Firms that previously competed on every front are now more open to sharing non-core functions, especially where the shared resource does not affect their competitive differentiation.
Who Is Affected?
The primary beneficiaries are mid-market medical device manufacturers, typically with annual revenues between £10 million and £250 million, that need ISO 13485 certification but cannot justify the full cost of an in-house calibration lab. This includes:
- Contract manufacturers that produce components or subassemblies for larger device companies.
- Specialist device makers in niches like orthopaedics, diagnostics, or surgical instruments.
- Start-ups and scale-ups that have received regulatory clearance but need to scale production without a parallel scaling of overheads.
Also affected are the calibration service providers themselves. Traditional third-party labs may see competition from shared models, but they may also find new opportunities to manage or host shared facilities. Larger OEMs may benefit indirectly if their suppliers adopt this model, potentially leading to more consistent quality and lower supply chain risk.
Commercial Impact
The commercial logic of shared calibration labs is straightforward: spread fixed costs across multiple users, increase utilisation of expensive equipment, and reduce the per-unit cost of calibration.
For a mid-market firm, the alternative is either to invest in its own calibration equipment (which may sit idle for much of the year) or to outsource to a commercial lab (which may have long lead times and less flexibility). A shared lab can offer a middle path: lower capital outlay than in-house, and faster turnaround than a distant third-party provider.
There are also potential savings in audit preparation. A shared lab with a well-documented quality system can provide the necessary records in a standardised format, reducing the time that quality managers spend collating evidence.
However, the model is not without cost. Membership fees, usage charges, and the need to align internal procedures with the lab's protocols can add complexity. Firms must also consider the risk of dependency: if the shared lab fails an audit or loses its accreditation, all members are affected.
Risks and Unknowns
The shared calibration lab model is still evolving, and several risks need careful assessment.
- Quality control: The lab must maintain its own quality system to ISO/IEC 17025 or equivalent. If it fails, all members face compliance gaps. The consortium must have clear governance and contingency plans.
- Confidentiality: Participating firms may be competitors in some markets. The lab must have strict data segregation and non-disclosure agreements to protect proprietary processes and product designs.
- Capacity planning: If one member experiences a surge in production, it may need more calibration slots than the lab can provide. The consortium must agree on priority rules and surge pricing.
- Regulatory acceptance: Not all notified bodies may view shared labs as acceptable evidence of control. Firms should confirm with their certification body before committing to the model.
- Long-term viability: If one or two major members leave, the lab's economics may break down. The consortium needs a sustainable membership agreement.
Why It Matters
For mid-market medical device firms, the choice of calibration strategy is not just a technical detail; it affects cost structure, audit readiness, and the ability to win contracts. Shared calibration labs offer a way to achieve ISO 13485 compliance without the full capital burden, potentially levelling the playing field with larger competitors.
For investors and operators, this model represents a new form of shared infrastructure in the medical device sector. It may also signal a broader trend towards collaborative compliance in regulated industries, where the cost of standards is rising but the willingness to share non-core functions is increasing.
FY Outlook
Over the next two to three years, we expect to see more formalised shared calibration arrangements, possibly with third-party operators managing the lab on behalf of a consortium. This could lead to the emergence of regional calibration hubs, particularly in clusters of medical device manufacturing such as the UK's Oxford-Cambridge arc, the US's Minneapolis area, and Germany's Tuttlingen region.
We also anticipate that accreditation bodies will develop clearer guidance on how shared labs should be assessed, which would reduce uncertainty and encourage adoption. In the longer term, digital calibration management platforms could integrate with shared labs, providing real-time traceability and automated audit trails.
However, the model will not suit every firm. Companies with highly specialised calibration needs, or those that treat calibration as a core competency, may still prefer in-house capabilities. The key is to assess the fit carefully.
Conclusion
Shared calibration labs are a pragmatic response to the cost and complexity of ISO 13485 compliance for mid-market medical device firms. They offer a way to access high-quality calibration services without the full capital outlay, and they align with broader trends towards shared services and supply chain resilience.
The model is not without risks, particularly around quality control and confidentiality, but with proper governance it could become a standard option for firms that need to demonstrate compliance without building a metrology department from scratch.
For commercial leaders, the message is clear: evaluate whether a shared calibration lab could reduce your compliance costs and improve audit readiness. If so, the next step is to assess potential partners and agree on a governance structure that protects all parties.
This article is for informational purposes only and does not constitute regulatory or legal advice. Firms should consult with their certification body and legal counsel before entering into any shared compliance arrangement.
